BeyondSpring (BYSI) Operating Leases (2019 - 2025)
BeyondSpring (BYSI) posted Operating Leases of $320000.0 for Q4 2025, up 244.09% sequentially from $93000.0 in Q3 2025, and up 4.23% YoY from $307000.0 in Q4 2024.
BeyondSpring (BYSI) Operating Leases (2019 - 2025) Analysis & Trends
BeyondSpring has reported Operating Leases for 7 years, with the latest figure at $320000.0 in Q4 2025.
- Quarterly Operating Leases rose 4.23% year-over-year to $320000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $320000.0 (up 4.23% YoY) and the FY2025 annual result came in at $320000.0, up 4.23% from the prior year.
- Operating Leases grew to $320000.0 in Q4 2025 per BYSI's latest filing, from $93000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $4.5 million in Q2 2022 and troughed at $93000.0 in Q3 2025.
- A 5-year average of $1.5 million and a median of $631000.0 in 2021 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2025: Operating Leases soared 673.53% in 2022, then slumped 94.39% in 2025.
- Over 5 years, Operating Leases stood at $1.5 million in 2021, then soared by 172.14% to $4.0 million in 2022, then plunged by 85.26% to $589000.0 in 2023, then plunged by 47.88% to $307000.0 in 2024, then rose by 4.23% to $320000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $320000.0, $93000.0, and $170000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - |
| 10 | BeyondSpring | 29.77 Mn | 29.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Jun 30, 2024 | 3.03 Mn |
| Dec 31, 2023 | 589,000.00 |
| Jun 30, 2023 | 3.69 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.47 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 578,000.00 |
| Mar 31, 2021 | 673,000.00 |
| Dec 31, 2020 | 1.36 Mn |
| Sep 30, 2020 | 1.55 Mn |
| Jun 30, 2020 | 1.75 Mn |
| Mar 31, 2020 | 1.89 Mn |
| Dec 31, 2019 | 1.94 Mn |
| Sep 30, 2019 | 2.09 Mn |